[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"norm-eurlex-reg_2023_607-art-3-de":3},{"law":4,"norm_id":14,"norm_key":15,"slug":16,"title":17,"chapter":18,"content":19,"enriched_content":20,"hierarchy":21,"neighbors_before":22,"neighbors_after":34,"citing_decisions":35,"is_thin":36},{"abbreviation":5,"title":6,"source_type":7,"jurisdiction":8,"document_kind":9,"language":10,"attribution":11,"version_date":12,"source_url":13},"reg_2023_607","zur Änderung der Verordnungen (EU) 2017\u002F745 und (EU) 2017\u002F746 hinsichtlich der Übergangsbestimmungen für bestimmte Medizinprodukte und In-vitro-Diagnostika","eurlex","eu","regulation","de","© Europäische Union, https:\u002F\u002Feur-lex.europa.eu","2024-10-15","https:\u002F\u002Feur-lex.europa.eu\u002Flegal-content\u002FDE\u002FALL\u002F?uri=CELEX:32023R0607",7116031,"Art. 3","art-3","Inkrafttreten",null,"Diese Verordnung tritt am Tag ihrer Veröffentlichung im Amtsblatt der Europäischen Union in Kraft.","REG_2023_607 - Art. 3 Inkrafttreten\n\nDiese Verordnung tritt am Tag ihrer Veröffentlichung im Amtsblatt der Europäischen Union in Kraft.",{},[23,27,31],{"norm_key":24,"title":25,"slug":26},"Art. 2","Änderungen der Verordnung (EU) 2017\u002F746","art-2",{"norm_key":28,"title":29,"slug":30},"Art. 1","Änderungen der Verordnung (EU) 2017\u002F745","art-1",{"norm_key":32,"title":18,"slug":33},"ErwGr. 13","erwgr-13",[],[],true]